You are here

atrasentan

Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins

BioSpace

Tue, 05/28/24 - 10:47 am

IgA nephropathy

Atrasentan data backs up Novartis’ $3.5bn Chinook deal

Pharmaphorum

Mon, 10/30/23 - 10:21 am

IgA nephropathy

Chinook Therapeutics

AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy

Yahoo

Mon, 05/20/13 - 11:21 am

diabetic neuropathy

Abbott drug meets goals in kidney disease study

Yahoo/AP

Tue, 11/23/10 - 08:56 am

Abbott Laboratories